Skip to Main Content

Paper Details

Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry.
Br J Ophthalmol
4
2023
Author NameAffiliation
Vuong NguyenClinical Ophthalmology and Eye Health, The University of Sydney Save Sight Institute
Ian L McAllisterUniversity of Western Australia, Lions Eye Institute
Hemal MehtaClinical Ophthalmology and Eye Health, The University of Sydney Save Sight Institute
Hemal MehtaRoyal Free London NHS Foundation Trust
Daniel BarthelmesClinical Ophthalmology and Eye Health, The University of Sydney Save Sight Institute
Daniel BarthelmesUniversity of Zurich
Mark C GilliesClinical Ophthalmology and Eye Health, The University of Sydney Save Sight Institute
  • 1 - 7

Datasets

Release 1.2